SCHEMBL4840756

SCHEMBL4840756

CC(C)(COc1ccc(CNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3ccccc3C(F)(F)F)cc2)cc1)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 5/20 0.45
POLB P06746 2/20 0.40
LMNA P02545 2/20 0.40
ALDH1A1 P00352 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39
KMT2A Q03164 2/20 0.38
EPHX2 P34913 1/20 0.38
MEN1 O00255 1/20 0.38
PPARD Q03181 1/20 0.37
PPARA Q07869 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37
TRPA1 O75762 1/20 0.37
FFAR1 O14842 1/20 0.37
MMP8 P22894 2/20 0.37
SCN10A Q9Y5Y9 1/20 0.37
MMP3 P08254 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4834117 0.94 SCN9A (0.44) SCN9APOLBLMNAALDH1A1NPSR1
SCHEMBL4841471 0.87 RORC (0.41) POLBLMNAALDH1A1NPSR1KMT2A
SCHEMBL4842829 0.86 SCN9A (0.48) SCN9APOLBLMNAHTTRECQL
SCHEMBL4832648 0.86 SCN9A (0.48) SCN9APOLBLMNAHTTRECQL
SCHEMBL4836962 0.85 SCN9A (0.46) SCN9APOLBLMNAHTTRECQL
SCHEMBL4036738 0.84 SCN9A (0.47) SCN9APOLBLMNAHTTRECQL
SCHEMBL4038373 0.84 SCN9A (0.46) SCN9APOLBLMNAHTTRECQL
SCHEMBL4845199 0.83 FFAR4 (0.44) SCN9AALDH1A1NPSR1FFAR4FFAR1
SCHEMBL4834142 0.81 RORC (0.39) POLBLMNAALDH1A1NPSR1KMT2A
SCHEMBL4842395 0.81 FFAR4 (0.43) ALDH1A1NPSR1FFAR4FFAR1MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 SCN9A 1845/4885POLB 4775/4885LMNA 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.